Ehud Rivlin

Verizon (United States) — United States

Engineering · Physical Sciences

41h-index10.4kcitations348works1.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Robotics and Sensor-Based Localization(86), Advanced Vision and Imaging(77), Advanced Image and Video Retrieval Techniques(57), Photodynamic Therapy Research Studies(48), Robotic Path Planning Algorithms(39)

Publications348 total

Computer Aided Polyp Detection Multi-center International Randomized Controlled Study with a Focus on Community Clinics: GAIN Clinical Trial
Gastrointestinal Endoscopy·2026
WAVECLIP: Wavelet Tokenization for Adaptive-Resolution CLIP
arXiv (Cornell University)·2025Open Access
MESSI: A Multi-Elevation Semantic Segmentation Image Dataset of an Urban Environment
arXiv (Cornell University)·2025Open Access
Supplementary Figure S11 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S10 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Table S4 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S5 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Material 1 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Material 4 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Table S1 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Material 3 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S6 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S9 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S1 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S7 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S4 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S2 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Table S2 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Figure S8 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
Supplementary Material 2 from Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer
2025Open Access
page 1 of 18Next →

Frequent Co-authors

Ilan Shimshoni(8), Michael Rudzsky(7), Ittay Weiss(5), A. Adam(4), Yossi Matias(4), I. Kamon(4), Ido Leichter(4), Michael Lindenbaum(4), Roman Goldenberg(3), Ron Kimmel(3), Elon Rimon(3), Evgeni Magid(3), David Doermann(3), Lev Finkelstein(2), Evgeniy Gabrilovich(2), Zach Solan(2), Gadi Wolfman(2), Eytan Ruppin(2), Rodrigo A. Botafogo(2), Ben Shneiderman(2)